Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard LeDuc

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
Emerging Microbes & Infections|January 30, 2026
TMPRSS2 inhibitors with broad-spectrum efficacy against SARS-CoV-2 (JN.1) and influenza A (H1N1) viruses protect mice from influenza A infectionLianne Presley, Jimena Pérez-Vargas, Anaïs Saintigny, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in miceTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Nature|March 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeuticTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Emerging Microbes & Infections|August 9, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariantsJimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, et al.
Antiviral Research|December 12, 2022
Discovery of lead natural products for developing pan-SARS-CoV-2 therapeuticsJimena Pérez-Vargas, Tirosh Shapira, Andrea D Olmstead, et al.
Pharmacological Reviews|March 27, 2026
Adhesion G protein-coupled receptorsTobias Langenhan, Garret R Anderson, Demet Araç, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Emerging Microbes & Infections|January 30, 2026
TMPRSS2 inhibitors with broad-spectrum efficacy against SARS-CoV-2 (JN.1) and influenza A (H1N1) viruses protect mice from influenza A infectionLianne Presley, Jimena Pérez-Vargas, Anaïs Saintigny, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in miceTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Nature|March 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeuticTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Emerging Microbes & Infections|August 9, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariantsJimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, et al.
Antiviral Research|December 12, 2022
Discovery of lead natural products for developing pan-SARS-CoV-2 therapeuticsJimena Pérez-Vargas, Tirosh Shapira, Andrea D Olmstead, et al.
Pharmacological Reviews|March 27, 2026
Adhesion G protein-coupled receptorsTobias Langenhan, Garret R Anderson, Demet Araç, et al.
Pageof 14